Lilly Reports Second-Quarter 2015 Results, Revises 2015 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Eli Lilly & Co. (LLY) Plans Expansion of San Diego-Located Biotechnology Center
July 23, 2015 6:33 AM EDTEli Lilly & Co. (NYSE: LLY) revealed plans to expand the Lilly Biotechnology Center located in San Diego, Calif. The expansion will effectively double Lilly's research presence in San Diego as the company seeks to develop new collaborations in one of the world's leading regions for drug research and development.
Set to be completed in 2016, the expansion will feature an additional 175,000 square feet of working space and is expected to generate up to 130 potential new job openings, yielding a... More
Eli Lilly & Co. (LLY) Tops Q2 EPS by 16c; Updates FY15 Outlook
July 23, 2015 6:26 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $0.90, $0.16 better than the analyst estimate of $0.74. Revenue for the quarter came in at $4.98 billion versus the consensus estimate of $4.89 billion.
The following table summarizes the company's 2015 financial guidance:
... More
